AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let al...
FDA Device Recall #Z-1582-2018 — Class II — February 27, 2018
Recall Summary
| Recall Number | Z-1582-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 27, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Radiometer Medical ApS |
| Location | Bronshoj, N/A |
| Product Type | Devices |
| Quantity | 2 |
Product Description
AQURE, Software version 2.3.0 and 2.3.1 Product Usage: The AQURE system is intended to let allow the management of analytical devices and operator profiles. The user can associate patient data with test data. The system shows test results. The system receives data from connected devices at the point-of care or laboratory. It can send test results to the HIS/LIS. The system lets the user send commands to selected devices. The system uses data related to the performance of devices, to tell users of issues to be managed. The AQURE system is intended for professional use.
Reason for Recall
There is a potential problem relating to the AQURE System, versions 2.3.0 and 2.3.1, that may result in patient mix-up.
Distribution Pattern
US Nationwide Distribution in the states to Georgia and Wisconsin.
Lot / Code Information
Version 2.3.0 and 2.3.1
Other Recalls from Radiometer Medical ApS
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1659-2025 | Class II | Radiometer ABL90 Series - Radiometer ABL90 FLEX... | Mar 21, 2025 |
| Z-2426-2024 | Class II | ABL800 FLEX Model Numbers 393-800 and 393-801 ... | May 31, 2024 |
| Z-1394-2023 | Class II | AQURE REF 933-599 Software Versions 2.5.2 2... | Mar 8, 2023 |
| Z-1321-2022 | Class II | ABL800 Flex Analyzer Model Numbers 393-800 and ... | May 18, 2022 |
| Z-1115-2022 | Class II | Radiometer, REF:956-552, PIC050- Arterial Blood... | Apr 8, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.